Shia CS - Search Results

1

Preclinical Studies of OBI-999: A Novel Globo H-Targeting Antibody-Drug Conjugate.

Yang MC, Shia CS, Li WF, Wang CC, Chen IJ, Huang TY, Chen YJ, Chang HW, Lu CH, Wu YC, Wang NH, Lai JS, Yu CD, Lai MT. Yang MC, et al. Among authors: shia cs. Mol Cancer Ther. 2021 Jun;20(6):1121-1132. doi: 10.1158/1535-7163.MCT-20-0763. Epub 2021 Mar 15. Mol Cancer Ther. 2021. PMID: 33722855

2

OBI-3424, a Novel AKR1C3-Activated Prodrug, Exhibits Potent Efficacy against Preclinical Models of T-ALL.

Evans K, Duan J, Pritchard T, Jones CD, McDermott L, Gu Z, Toscan CE, El-Zein N, Mayoh C, Erickson SW, Guo Y, Meng F, Jung D, Rathi KS, Roberts KG, Mullighan CG, Shia CS, Pearce T, Teicher BA, Smith MA, Lock RB. Evans K, et al. Among authors: shia cs. Clin Cancer Res. 2019 Jul 15;25(14):4493-4503. doi: 10.1158/1078-0432.CCR-19-0551. Epub 2019 Apr 23. Clin Cancer Res. 2019. PMID: 31015346 Free PMC article.

3

A novel selective AKR1C3-activated prodrug AST-3424/OBI-3424 exhibits broad anti-tumor activity.

Meng F, Li WF, Jung D, Wang CC, Qi T, Shia CS, Hsu RY, Hsieh YC, Duan J. Meng F, et al. Among authors: shia cs. Am J Cancer Res. 2021 Jul 15;11(7):3645-3659. eCollection 2021. Am J Cancer Res. 2021. PMID: 34354865 Free PMC article.

4

First-in-Human Study of OBI-999, a Globo H-Targeting Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors.

Tsimberidou AM, Vo HH, Beck J, Shia CS, Hsu P, Pearce TE. Tsimberidou AM, et al. Among authors: shia cs. JCO Precis Oncol. 2023 Jan;7:e2200496. doi: 10.1200/PO.22.00496. JCO Precis Oncol. 2023. PMID: 36701651 Free PMC article. Clinical Trial.

5

Potential risk of mulberry-drug interaction: modulation on P-glycoprotein and cytochrome P450 3A.

Hsu PW, Shia CS, Lin SP, Chao PD, Juang SH, Hou YC. Hsu PW, et al. Among authors: shia cs. J Agric Food Chem. 2013 May 8;61(18):4464-9. doi: 10.1021/jf3052384. Epub 2013 Apr 29. J Agric Food Chem. 2013. PMID: 23590720

6

Suppression on metastasis by rhubarb through modulation on MMP-2 and uPA in human A549 lung adenocarcinoma: an ex vivo approach.

Shia CS, Suresh G, Hou YC, Lin YC, Chao PD, Juang SH. Shia CS, et al. J Ethnopharmacol. 2011 Jan 27;133(2):426-33. doi: 10.1016/j.jep.2010.10.020. Epub 2010 Oct 21. J Ethnopharmacol. 2011. PMID: 20970489

7

Metabolism and pharmacokinetics of 3,3',4',7-tetrahydroxyflavone (fisetin), 5-hydroxyflavone, and 7-hydroxyflavone and antihemolysis effects of fisetin and its serum metabolites.

Shia CS, Tsai SY, Kuo SC, Hou YC, Chao PD. Shia CS, et al. J Agric Food Chem. 2009 Jan 14;57(1):83-9. doi: 10.1021/jf802378q. J Agric Food Chem. 2009. PMID: 19090755

8

Metabolism and pharmacokinetics of san-huang-xie-xin-tang, a polyphenol-rich chinese medicine formula, in rats and ex-vivo antioxidant activity.

Shia CS, Hou YC, Juang SH, Tsai SY, Hsieh PH, Ho LC, Chao PD. Shia CS, et al. Evid Based Complement Alternat Med. 2011;2011:721293. doi: 10.1093/ecam/nep124. Epub 2011 Jun 7. Evid Based Complement Alternat Med. 2011. PMID: 19737807 Free PMC article.

9

Metabolism and pharmacokinetics of anthraquinones in Rheum palmatum in rats and ex vivo antioxidant activity.

Shia CS, Juang SH, Tsai SY, Chang PH, Kuo SC, Hou YC, Chao PD. Shia CS, et al. Planta Med. 2009 Oct;75(13):1386-92. doi: 10.1055/s-0029-1185725. Planta Med. 2009. PMID: 19877312

10

Potential ex vivo immunomodulatory effects of San-Huang-Xie-Xin-Tang and its component herbs on mice and humans.

Li CY, Hou YC, Lee Chao PD, Shia CS, Hsu IC, Fang SH. Li CY, et al. Among authors: shia cs. J Ethnopharmacol. 2010 Feb 3;127(2):292-8. doi: 10.1016/j.jep.2009.11.006. Epub 2009 Nov 10. J Ethnopharmacol. 2010. PMID: 19903515

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

19 results

Search Page